Sussan-Mari’s master research focused on the use of in silico molecular docking and synthesis to design libraries of anti-cholinergic agents and potential NMDA agonists as neuroprotective agents for the treatment of Alzhimer’s and Parkinson’s disease.


The design and synthesis of potential acetylcholinesterase inhibitors and NMDA antagonists as neuroprotective agents


  1. 47th IUPAC World Chemistry Congress, Paris, France, July, 2019: Synthesis of novel Alzheimer’s disease drugs based on a pyrazole core, S. Botha*, D.L. Riley, J.-L. Panayides